Fadoua Louglali | Medical Microbiology | Best Researcher Award

Published on by Young Scientists Awards

Ms. Fadoua Louglali | Medical Microbiology
| Best Researcher Award

Industrial and Surface Engineering Laboratory | Morocco

Ms. Fadoua Louglali is a dedicated researcher and Ph.D. student specializing in Natural Resources, Environment, and Health at the Industrial and Surface Engineering Laboratory, Bioprocess and Biointerfaces Team, Faculty of Sciences and Techniques Beni-Mellal, Morocco. Her academic journey includes a Master’s in Science and Technology with a focus on Quality Management in Agri-Food Industries and a License in Technology and Quality of Agri-Food Products. She has accumulated practical experience through multiple internships, including contributions to upgrading the  management systems at ELDIN S.A., reliability studies at Centrale DANONE, validation of physicochemical methods at the National Office for Food Safety, and microbiological analyses at a regional hospital in Beni-Mellal. Fadoua’s research focuses on the physicochemical and microbiological characterization of surfaces, particularly gallstones, to understand their interactions with pathogenic bacteria such as Salmonella Typhi. She has published work in Current Microbiology (1 document, 0 citations, h-index 0) and presented her findings through multiple national scientific communications and posters, exploring factors influencing biofilm formation and the chemical, microstructural, and elemental properties of gallstones. Her multidisciplinary expertise combines analytical chemistry, microbiology, and food safety, reflecting her commitment to advancing health and environmental research. With strong technical skills, a robust research record, and international collaborations, she continues to contribute to the understanding of pathogen-surface interactions and their implications for public health.

Profile: Orcid | Scopus 

Featured Publication

Louglali, F. (2025). Physicochemical characterization of gallstone surfaces to predict their interaction with Salmonella Typhi. Current Microbiology.

Srinivasa Reddy Bonam | Immunology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Srinivasa Reddy Bonam | Immunology | Young Scientist Award

Senior Scientist | Indian Institute of Chemical Technology | India

Dr. Srinivasa Reddy Bonam is a distinguished scientist specializing in immunology, vaccine development, and pharmacology, with a significant research impact demonstrated by over 4,892 citations from 4,654 documents and an h-index of 29. He currently serves as an Assistant Professor at the Academy of Scientific and Innovative Research (AcSIR) and Senior Scientist at CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, India. His extensive research experience spans advanced vaccine design, mRNA therapeutics, immunomodulators, and host-pathogen interactions. Dr. Bonam completed his Ph.D. at CSIR-IICT, Hyderabad, focusing on the immunopharmacological evaluation of novel glycopeptides and glycolipids as vaccine adjuvants and immunomodulators. His doctoral research led to the identification of multiple lead adjuvant candidates, with one licensed by Bharat Biotech International Ltd for emerging vaccines. After his Ph.D., he pursued postdoctoral research in Europe and the USA, contributing to the development of therapeutic peptides for autoimmune diseases at the University of Strasbourg, innovative immune regulation mechanisms in fungal infections and COVID-19 at INSERM Paris, and designing novel mRNA vaccines at the University of Texas Medical Branch (UTMB) in collaboration with Prof. Drew Weissman’s lab. Dr. Bonam has received honors including the Marie Curie Fellowship (self-denied), Outstanding Reviewer Awards from MDPI journals, and the Distinguished Alumni Award from CIPS. He serves as Editor-in-Chief of Advances in Pharmacology and Pharmacy, editorial board member of multiple journals, and peer reviewer for over 90 scientific journals. His pioneering contributions include patents on novel vaccine adjuvants and the development of Uttroside, a saponin-based vaccine adjuvant licensed to Bharat Biotech International Ltd. Driven by a commitment to next-generation vaccines and therapeutic strategies, Dr. Bonam continues to address emerging global health challenges through his high-impact research.

Profile: Scopus

Featured Publications

  1. Alameh, M.-G., Semon, A., Hu, H., Bonam, S. R., Maslanka, J. R., Weissman, D., & Zackular, J. P. (2024). A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection. Science, 386(6717), 69–75.

  1. Bonam, S. R., Hazell, N. C., Mathew, M. J., Liang, Y., Zhang, X., Wei, Z., Alameh, M.-G., Weissman, D., & Hu, H. (2024). Innate and adaptive immune parameters following mRNA vaccination in mice. Vaccines, 12(5), 543.

  1. Ye, Z., Bonam, S. R., McKay, L. G. A., Plante, J. A., Walker, J., Zhao, Y., Huang, C., … Hu, H. (2023). Monovalent SARS-CoV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. Proceedings of the National Academy of Sciences, 120(52), e2311752120.

  2. Bonam, S. R., Platenburg, P. P., & Bayry, J. (2022). Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen-presenting cells. Frontiers in Immunology, 13, 7738.

  3. Hajnik, R. L., Plante, J. A., Liang, Y., Alameh, M.-G., Tang, J., Bonam, S. R., … Hu, H. (2022). Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models. Science Translational Medicine, 14, eabq1945.

Yǒng zhāng | Immunology | Best Researcher Award

Published on by Young Scientists Awards

Assoc Prof Dr. Yǒng zhāng | Immunology  | Best Researcher Award

Assoc Prof Dr at Jilin University, China

Dr. Yong Zhang is an Associate Professor at the School of Life Sciences, Jilin University, China. He has been with Jilin University since 2010, progressing from a Post-Doc to Lecturer, and now, Associate Professor. Dr. Zhang earned his Ph.D. in Pharmacy from Shenyang Pharmaceutical University and had the opportunity to be a Visiting Ph.D. Student at the University of East Anglia, UK. His research focuses on pharmaceutical sciences and molecular biology, contributing significantly to fields like immunology, drug delivery systems, and vaccine development. Dr. Zhang has published extensively in peer-reviewed journals, with notable works on immune responses and drug solubility enhancement.

 

Profile

Scopus

 

Orcid

🎓 Education

PhD in Pharmacy (2003-2009) Shenyang Pharmaceutical University, Shenyang, Liaoning, CN Yong Zhang earned his PhD from the School of Pharmacy at Shenyang Pharmaceutical University, deepening his expertise in pharmaceutical sciences. Visiting PhD Student (2008-2009)
University of East Anglia, Norwich, Norfolk, GB During his PhD, Yong Zhang enriched his research experience at the University of East Anglia, focusing on advanced pharmaceutical studies.. BSc in Pharmacy (1998-2003) Shenyang Pharmaceutical University, Shenyang, Liaoning, CN
Yong Zhang completed his Bachelor’s degree in Pharmacy, laying the foundation for his future academic and professional pursuits in pharmaceutical sciences.

🧑‍🏫 Employment

Associate Professor (2017-Present) School of Life Sciences, Jilin University, Changchun, Jilin, CN Yong Zhang has been serving as an Associate Professor, contributing to the academic growth and research advancements in life sciences.. Lecturer (2012-2017) School of Life Sciences, Jilin University, Changchun, Jilin, CN Prior to his current role, Yong Zhang worked as a Lecturer, where he played a pivotal role in teaching and guiding students in life sciences. Post Doc (2010-2012) School of Life Sciences, Jilin University, Changchun, Jilin, CN Yong Zhang conducted postdoctoral research, focusing on cutting-edge life sciences projects and innovations.

📚  Publications

  1. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice
    • Authors: Dongdong Li, Lijun Bian, Lili Cui, Jingying Zhou, Gaotian Li, Xiaoyan Zhao, Liao Xing, Jiaxing Cui, Bo Sun, Chunlai Jiang, Wei Kong, Yong Zhang*, Yan Chen*
    • Journal: International Journal of Nanomedicine
    • Publication Year: 2024
    • Volume: 19
    • Pages: 8029–8042

 

  1. Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice
    • Authors: H Zhao, P Li, L Bian, W Zhang, C Jiang, Y Chen*, W Kong, Y Zhang*
    • Journal: International Journal of Molecular Sciences
    • Publication Year: 2023
    • Volume: 24
    • Issue: 17
    • Article ID: 13587

 

  1. Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
    • Authors: L Bian, Y Zheng, X Guo, D Li, J Zhou, L Jing, Y Chen, J Lu, K Zhang, C Jiang*, Y Zhang*, W Kong
    • Journal: Frontiers in Immunology
    • Publication Year: 2022
    • Volume: 13
    • Article ID: 938598

 

  1. Immune Response of C57BL/6J Mice to Herpes Zoster Subunit Vaccines Formulated with Nanoemulsion-Based and Liposome-Based Adjuvants
    • Authors: L He, B Sun, Y Guo, K Yan, D Liu, Y Zang, C Jiang*, Y Zhang*, W Kong
    • Journal: International Immunopharmacology
    • Publication Year: 2021
    • Volume: 101
    • Article ID: 108216

 

  1. Respiratory Syncytial Virus F Subunit Vaccine with AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice
    • Authors: Y Zheng, L Bian, H Zhao, Y Liu, J Lu, D Liu, K Zhang, Y Song, Y Luo, C Jiang*, Yan Chen, Y Zhang*, W Kong
    • Journal: Frontiers in Immunology
    • Publication Year: 2020
    • Volume: 11
    • Article ID: 526965

 

  1. The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
    • Authors: Li F, Chen Y, Liu S, Pan X, Liu Y, Zhao H, Yin X, Yu C, Kong W, Zhang Y*
    • Journal: International Journal of Nanomedicine
    • Publication Year: 2019
    • Volume: 14
    • Pages: 9917-9928